Ted Love

Ted Love

Director/Board Member at STRUCTURE THERAPEUTICS INC.

Net worth: 1 M $ as of 29/04/2024

65 year
Health Technology
Commercial Services
Consumer Services

Profile

Ted W.
Love
is currently serving as the Chairman of the Biotechnology Innovation Organization.
He is also an Independent Director at Gilead Sciences, Inc., Avillion LLP, Structure Therapeutics, Inc., Royalty Pharma Plc, and Life Science Cares Bay Area.
In his former positions, Dr. Love served as the Chairman, President & Chief Executive Officer of Nuvelo, Inc. from 2001 to 2009.
He was also the President, Chief Executive Officer & Director of Global Blood Therapeutics, Inc. from 2013 to 2022.
Additionally, he served as an Independent Director at Bio-Rad Laboratories, Inc. from 2010 to 2013, Seagen Inc. from 2020 to 2023, Mast Therapeutics, Inc. from 2012 to 2013, Santarus, Inc. from 2005 to 2014, Amicus Therapeutics, Inc. from 2012 to 2020, Humanigen, Inc. from 2009 to 2015, Portola Pharmaceuticals LLC from 2019 to 2020, ARCA biopharma, Inc. from 2001 to 2009 and again from 2009 to 2011, Cascadian Therapeutics LLC from 2013 to 2018, Affymax, Inc. from 2006 to 2013, and as a Director at Predix Pharmaceuticals, Inc., Stanford Health Care, California Healthcare Institute, California Institute for Regenerative Medicine, and The Biotechnology Institute.
Dr. Love received his undergraduate degree from Haverford College and his doctorate from Yale School of Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
11/04/2024 29,194 ( 0.01% ) 820 643 $ 29/04/2024
07/05/2024 2,822 ( 0.00% ) 184 192 $ 29/04/2024
18/04/2024 0 ( -.--% ) - $ 29/04/2024

Ted Love active positions

CompaniesPositionStart
ROYALTY PHARMA PLC Director/Board Member 29/07/2020
STRUCTURE THERAPEUTICS INC. Director/Board Member 02/08/2023
GILEAD SCIENCES, INC. Director/Board Member 31/01/2024
Life Science Cares Bay Area Director/Board Member -
Chairman -
Director/Board Member 21/07/2013
All active positions of Ted Love

Former positions of Ted Love

CompaniesPositionEnd
SEAGEN INC. Director/Board Member 13/12/2023
GLOBAL BLOOD THERAPEUTICS, INC. Chief Executive Officer 04/10/2022
AMICUS THERAPEUTICS, INC. Director/Board Member 07/08/2020
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Ted Love's experience

Training of Ted Love

Haverford College Undergraduate Degree
Yale School of Medicine Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ted Love's experience

Connections

100 +

1st degree connections

31

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies9
BIO-RAD LABORATORIES, INC.

Health Technology

GILEAD SCIENCES, INC.

Health Technology

AMICUS THERAPEUTICS, INC.

Health Technology

HUMANIGEN, INC.

Health Technology

AFFYMAX, INC.

Health Technology

INNOVIVA, INC.

Health Technology

ARCA BIOPHARMA, INC.

Health Technology

STRUCTURE THERAPEUTICS INC.

Commercial Services

ROYALTY PHARMA PLC

Health Technology

Private companies20

Health Technology

Health Technology

Nuvelo, Inc.

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Services

California Healthcare Institute

Health Technology

California Institute for Regenerative Medicine

Government

Commercial Services

Health Technology

Commercial Services

Life Science Cares Bay Area

Health Technology

See company connections